A Crohn’s Conundrum: Can the Faecal Calprotectin Level Act as a Sensitive Cut-off to Prevent Unnecessary MRI Small Bowel Scans?
Journal Title: Radiology – Open Journal - Year 2017, Vol 2, Issue 2
Abstract
Background: Current gastroenterology practice in evaluating those with diarrhoeal symptoms and a positive faecal calprotectin (CP) is to perform colonoscopy. Colonoscopy however is limited, in that it cannot exclude disease proximal to the terminal ileum. Therefore, for many patients not known to have Crohn’s disease, gastroenterologists are often concerned about the possibility of more proximal small bowel Crohn’s and request an magnetic resonance imaging (MRI) small bowel scan. Aims: This is the first study to investigate whether patients with a clinical suspicion of Crohn’s but with a normal colonoscopy will benefit from MRI in terms of diagnostic evaluation if they have a CP below the cut-off. Method: MRI small bowel reports, CP levels and colonoscopy reports were analysed (where obtainable) from 422 scans at a district general hospital in Stevenage, between 02/04/2015 and 21/07/2017. Eighty-five patients had features suggestive of Crohn’s but had normal colonoscopy findings. These were divided into those who had a CP above or below 600. Results: Within 55 patients who had a calprotectin below 600, we report that none (0%) of these patients were found to have significantly positive findings for Crohn’s on subsequent MRI. Amongst 30 patients with a positive CP, 8 (26.6%) were found to have active disease on MRI. The sensitivity of calprotectin was therefore identified to be 100% (95% CI 63.06% to 100%) and the specificity of the test was 71.43 % (95% CI 60% to 81.15%). Negative predictive value (NPV) was 1.00 and positive predictive value (PPV) was 0.27. Conclusion: Our study is the first to suggest that in patients with features of Crohn’s who have a normal colonoscopy, calprotectin performs impressively as a sensitive marker of the presence of small bowel inflammation on subsequent MRI. Further prospective studies would be needed to validate a potential approach of using the biomarker as a cut-off to reduce unnecessary MRI small bowel scans.
Authors and Affiliations
Faraz Hosseini-Ardehali
Keywords
Related Articles
- EP ID EP554412
- DOI 10.17140/ROJ-2-117
- Views 119
- Downloads 0
An Attempt to Integrate Diffusion Weighted and Dynamic Contrast Enhanced MRI
Diffusion Weighted MRI (DWI) and Dynamic Contrast Enhanced MRI (DCE-MRI) are increasingly used for cancer assessment. Both modalities require adequate post-processing to extract useful information. DWI can be analyzed us...
The Impact of Industrialization on London Health
A new multidisciplinary project funded by the City of London Archaeological Trust (CoLAT) Rosemary Green grant will be using the latest imaging techniques on a large sample of archaeological skeletal assemblages from sev...
Two Case Reports of Angioleiomyoma of the Finger
Angioleiomyoma represents a benign stromal tumor, which usually occurs in the subcutaneous tissue of the extremities. The angioleiomyoma in the finger is rare. We report 2 rare cases of an angioleiomyoma in finger. Case...
Update on Limbic Connections in Human Brain: A Possible Closer Relationship Between Brain Processes and Visceral Information
The limbic system includes cortical and subcortical brain structures involved in several functions, first of all emotional and memory processes and integration. Two key structures of the limbic network are hippocampus an...
License versus Non-License States
Technologists in the imaging modalities (radiology, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclear medicine, etc.), mostly are required to obtain a certification and state license for whi...